Toxoplasmosis neuroretinitis

Ophthalmology. 1993 Aug;100(8):1177-82. doi: 10.1016/s0161-6420(13)31511-5.

Abstract

Background: Neuroretinitis is a distinct clinical entity consisting of moderate to severe visual loss, optic nerve head edema, macular exudate in a stellate pattern, and variable vitreous inflammation. Although the etiology is usually postviral or idiopathic, an acute infectious cause occasionally is demonstrated.

Methods: Five juvenile or young adult patients with neuroretinitis are presented with serologic evidence of Toxoplasma gondii infection. Four of the five patients were treated with systemic antibiotics and corticosteroids; one patient was not treated.

Results: With a mean follow-up period of 50 months, visual acuity returned to 20/25 or better in four patients, with one patient regaining visual acuity of 20/60. Two patients had one or more recurrent episodes of neuroretinitis, distinguishing toxoplasmosis from idiopathic neuroretinitis, which is usually a monophasic illness.

Conclusion: Toxoplasmosis infection is a rare, but potentially treatable, form of neuroretinitis and should be included in the differential diagnosis of "Leber's idiopathic stellate retinopathy."

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Female
  • Humans
  • Male
  • Optic Neuritis / drug therapy
  • Optic Neuritis / parasitology*
  • Optic Neuritis / physiopathology
  • Prednisone / therapeutic use
  • Recurrence
  • Retinitis / drug therapy
  • Retinitis / parasitology*
  • Retinitis / physiopathology
  • Toxoplasmosis, Ocular* / drug therapy
  • Toxoplasmosis, Ocular* / physiopathology
  • Visual Acuity

Substances

  • Anti-Bacterial Agents
  • Prednisone